Come up with a name for your new list and we'll add to it:
Adello Biologics raised a round of funding on July 20, 2010. Investors include
Capital Midwest Fund.
Adello, formerly Therapeutic Proteins International, is a privately held, U.S.-based biotechnology company that leads with science to accelerate development and drive manufacturing efficiency. The com…